MA23.01 Phase II Trial of an Oral FGFR Inhibitor AZD4547 as...

Journal of Thoracic Oncology 2019 / 10 Vol. 14; Iss. 10

MA23.01 Phase II Trial of an Oral FGFR Inhibitor AZD4547 as Second or Third Line Therapy in Malignant Pleural Mesothelioma: Final Results of FRAME Study

Lam, W., Nowak, A., Chen, F., Muruganandan, S., Arunachalam, S., Chin, M., Millward, M., Read, C., Murray, K., Creaney, J., Lee, Y.C.G.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
14
Journal:
Journal of Thoracic Oncology
DOI:
10.1016/j.jtho.2019.08.691
Date:
October, 2019
File:
PDF, 112 KB
2019
Conversion to is in progress
Conversion to is failed